BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 7969229)

  • 1. Octreotide treatment of carcinoid hypertensive crisis.
    Warner RR; Mani S; Profeta J; Grunstein E
    Mt Sinai J Med; 1994 Sep; 61(4):349-55. PubMed ID: 7969229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uneventful spinal anesthesia for a patient with carcinoid syndrome managed with long-acting octreotide.
    Orbach-Zinger S; Lombroso R; Eidelman LA
    Can J Anaesth; 2002; 49(7):678-81. PubMed ID: 12193484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Update on the anesthetic management of patients with malignant carcinoid syndrome].
    Rodríguez-Cosmen C; Trillo Urrutia L; Pacreu Terradas S; Comps Vicente O; Escolano Villén F
    Rev Esp Anestesiol Reanim; 2005 May; 52(5):291-4. PubMed ID: 15968907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term management of the carcinoid syndrome. Treatment with octreotide alone and in combination with alpha-interferon.
    Janson ET; Oberg K
    Acta Oncol; 1993; 32(2):225-9. PubMed ID: 7686765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A prolonged-action somatostatin analog and carcinoid syndrome].
    Chayvialle JA
    Bull Acad Natl Med; 1989 May; 173(5):643-50; discussion 650-1. PubMed ID: 2478266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMS 201-995 and provocation tests in preparation of patients with carcinoids for surgery or hepatic arterial embolization.
    Ahlman H; Ahlund L; Dahlström A; Martner J; Stenqvist O; Tylén U
    Anesth Analg; 1988 Dec; 67(12):1142-8. PubMed ID: 2461665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mega-dose intravenous octreotide for the treatment of carcinoid crisis: a systematic review.
    Seymour N; Sawh SC
    Can J Anaesth; 2013 May; 60(5):492-9. PubMed ID: 23328959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anaphylactic reaction versus carcinoid crisis: the role of octreotide as a vasoconstrictor].
    Etxaniz Alvarez A; Pita Zapata E; González Vázquez M; López Pérez M; Abeledo Fernánndez MA
    Rev Esp Anestesiol Reanim; 2004; 51(7):395-8. PubMed ID: 15495639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Symptomatic treatment of the malignant carcinoid syndrome with octreotide].
    Alberts AS; Falkson G
    S Afr Med J; 1989 Jan; 75(1):30-1. PubMed ID: 2911781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of carcinoid syndrome with a somatostatin analogue].
    Döbrönte Z; Stöckert A; Végh G; Varga L
    Orv Hetil; 1992 Mar; 133(12):731-4. PubMed ID: 1372969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of malignant carcinoid syndrome with a long-acting somatostatin analogue.
    Altman AR; Tschen JA; Rice L
    Arch Dermatol; 1989 Mar; 125(3):394-6. PubMed ID: 2923448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orthotopic liver transplantation for carcinoid tumour metastatic to the liver: anesthetic management.
    Claure RE; Drover DD; Haddow GR; Esquivel CO; Angst MS
    Can J Anaesth; 2000 Apr; 47(4):334-7. PubMed ID: 10764178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of effective prophylaxis against intraoperative carcinoid crisis.
    Woltering EA; Wright AE; Stevens MA; Wang YZ; Boudreaux JP; Mamikunian G; Riopelle JM; Kaye AD
    J Clin Anesth; 2016 Aug; 32():189-93. PubMed ID: 27290972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome.
    Saslow SB; O'Brien MD; Camilleri M; von der Ohe M; Homburger HA; Klee GG; Pitot HC; Rubin J
    Am J Gastroenterol; 1997 Dec; 92(12):2250-6. PubMed ID: 9399764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoid crisis 24 hours after bland embolization: A case report.
    Fujie S; Zhou W; Fann P; Yen Y
    Biosci Trends; 2010 Jun; 4(3):143-4. PubMed ID: 20592464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of octreotide on basal and stimulated hormone levels in patients with carcinoid syndrome.
    Oberg K; Norheim I; Theodorsson E; Ahlman H; Lundqvist G; Wide L
    J Clin Endocrinol Metab; 1989 Apr; 68(4):796-800. PubMed ID: 2466045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous infusion of octreotide combined with perioperative octreotide bolus does not prevent intraoperative carcinoid crisis.
    Condron ME; Pommier SJ; Pommier RF
    Surgery; 2016 Jan; 159(1):358-65. PubMed ID: 26603846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A favorable response to the somatostatin analog SMS 201-995 in a patient with the carcinoid syndrome].
    Del Val A; Ponce J; Talens A; Martí-Bonmati L; Garrigues V; Berenguer J
    Rev Esp Enferm Dig; 1991 Mar; 79(3):215-7. PubMed ID: 2043408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Carcinoid tumor--diagnostic and therapeutic problems].
    Batowski S; Bielewicz A
    Pol Tyg Lek; 1994 Jun 6-13; 49(23-24):536-7. PubMed ID: 7675710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative management of patients with carcinoid heart disease having valvular surgery: a review of one hundred consecutive cases.
    Weingarten TN; Abel MD; Connolly HM; Schroeder DR; Schaff HV
    Anesth Analg; 2007 Nov; 105(5):1192-9, table of contents. PubMed ID: 17959940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.